Direct injection of autologous mesenchymal stromal cells improves myocardial function

Yifu Zhou, Suna Wang, Zuxi Yu, Robert F. Hoyt, Vandana Sachdev, Pamela Vincent, Andrew E. Arai, Minjung Kwak, Sandra Sczerba Burkett, Keith A. Horvath

Research output: Contribution to journalArticle

Abstract

Cell-based therapies have been employed with conflicting results. Whether direct injection of ex-vivo expanded autologous marrow stromal cells (MSCs) would improve the function of ischemic myocardium and enhance angiogenesis is not well defined. In a porcine model of chronic ischemia, MSCs were isolated and cultured for 4 weeks. Sixteen animals were random divided into two groups to receive either direct intramyocardial injection of autologous MSCs, or equal volumes and injections sites of saline. Cine MRI and epicardial echocardiography were performed just prior to the injections and again 6 weeks later at the time of sacrifice at which point tissue was also analyzed. Myocardial function as assessed by regional wall thickening (as measured by dobutamine stress echocardiograms) demonstrated a 40.9% improvement after cell treatment of the ischemic zone (p = 0.016) whereas the saline treated animals only had a 3.7% change (p = 0.82) compared to baseline. The left ventricular ejection fractions of MSC group showed 19.5% improvement from baseline 35.9 ± 3.8% to 42.9 ± 5.8% (p = 0.049). Increased vascularity was found in the MSC group compared to controls (0.80 ± 0.30 vs 0.50 ± 0.19 capillary/myocyte ratio, p = 0.018). Direct injection of autologous MSCs promotes angiogenesis and enhances the functional improvements following chronic myocardial ischemia. This suggests that the angiogenesis engendered by cell treatment may be physiologically meaningful by improving the contractility of ischemic myocardium.

Original languageEnglish (US)
Pages (from-to)902-907
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume390
Issue number3
DOIs
StatePublished - Dec 18 2009
Externally publishedYes

Fingerprint

Direct injection
Stromal Cells
Mesenchymal Stromal Cells
Bone Marrow
Injections
Animals
Echocardiography
Dobutamine
Magnetic resonance imaging
Myocardium
Cine Magnetic Resonance Imaging
Tissue
Cell- and Tissue-Based Therapy
Stroke Volume
Muscle Cells
Myocardial Ischemia
Swine
Ischemia
Therapeutics

Keywords

  • Mesenchymal stromal cells
  • Myocardial function
  • Myocardial ischemia

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Direct injection of autologous mesenchymal stromal cells improves myocardial function. / Zhou, Yifu; Wang, Suna; Yu, Zuxi; Hoyt, Robert F.; Sachdev, Vandana; Vincent, Pamela; Arai, Andrew E.; Kwak, Minjung; Burkett, Sandra Sczerba; Horvath, Keith A.

In: Biochemical and Biophysical Research Communications, Vol. 390, No. 3, 18.12.2009, p. 902-907.

Research output: Contribution to journalArticle

Zhou, Y, Wang, S, Yu, Z, Hoyt, RF, Sachdev, V, Vincent, P, Arai, AE, Kwak, M, Burkett, SS & Horvath, KA 2009, 'Direct injection of autologous mesenchymal stromal cells improves myocardial function', Biochemical and Biophysical Research Communications, vol. 390, no. 3, pp. 902-907. https://doi.org/10.1016/j.bbrc.2009.10.074
Zhou, Yifu ; Wang, Suna ; Yu, Zuxi ; Hoyt, Robert F. ; Sachdev, Vandana ; Vincent, Pamela ; Arai, Andrew E. ; Kwak, Minjung ; Burkett, Sandra Sczerba ; Horvath, Keith A. / Direct injection of autologous mesenchymal stromal cells improves myocardial function. In: Biochemical and Biophysical Research Communications. 2009 ; Vol. 390, No. 3. pp. 902-907.
@article{d3453409259044b19691a4f1840847c5,
title = "Direct injection of autologous mesenchymal stromal cells improves myocardial function",
abstract = "Cell-based therapies have been employed with conflicting results. Whether direct injection of ex-vivo expanded autologous marrow stromal cells (MSCs) would improve the function of ischemic myocardium and enhance angiogenesis is not well defined. In a porcine model of chronic ischemia, MSCs were isolated and cultured for 4 weeks. Sixteen animals were random divided into two groups to receive either direct intramyocardial injection of autologous MSCs, or equal volumes and injections sites of saline. Cine MRI and epicardial echocardiography were performed just prior to the injections and again 6 weeks later at the time of sacrifice at which point tissue was also analyzed. Myocardial function as assessed by regional wall thickening (as measured by dobutamine stress echocardiograms) demonstrated a 40.9{\%} improvement after cell treatment of the ischemic zone (p = 0.016) whereas the saline treated animals only had a 3.7{\%} change (p = 0.82) compared to baseline. The left ventricular ejection fractions of MSC group showed 19.5{\%} improvement from baseline 35.9 ± 3.8{\%} to 42.9 ± 5.8{\%} (p = 0.049). Increased vascularity was found in the MSC group compared to controls (0.80 ± 0.30 vs 0.50 ± 0.19 capillary/myocyte ratio, p = 0.018). Direct injection of autologous MSCs promotes angiogenesis and enhances the functional improvements following chronic myocardial ischemia. This suggests that the angiogenesis engendered by cell treatment may be physiologically meaningful by improving the contractility of ischemic myocardium.",
keywords = "Mesenchymal stromal cells, Myocardial function, Myocardial ischemia",
author = "Yifu Zhou and Suna Wang and Zuxi Yu and Hoyt, {Robert F.} and Vandana Sachdev and Pamela Vincent and Arai, {Andrew E.} and Minjung Kwak and Burkett, {Sandra Sczerba} and Horvath, {Keith A.}",
year = "2009",
month = "12",
day = "18",
doi = "10.1016/j.bbrc.2009.10.074",
language = "English (US)",
volume = "390",
pages = "902--907",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Direct injection of autologous mesenchymal stromal cells improves myocardial function

AU - Zhou, Yifu

AU - Wang, Suna

AU - Yu, Zuxi

AU - Hoyt, Robert F.

AU - Sachdev, Vandana

AU - Vincent, Pamela

AU - Arai, Andrew E.

AU - Kwak, Minjung

AU - Burkett, Sandra Sczerba

AU - Horvath, Keith A.

PY - 2009/12/18

Y1 - 2009/12/18

N2 - Cell-based therapies have been employed with conflicting results. Whether direct injection of ex-vivo expanded autologous marrow stromal cells (MSCs) would improve the function of ischemic myocardium and enhance angiogenesis is not well defined. In a porcine model of chronic ischemia, MSCs were isolated and cultured for 4 weeks. Sixteen animals were random divided into two groups to receive either direct intramyocardial injection of autologous MSCs, or equal volumes and injections sites of saline. Cine MRI and epicardial echocardiography were performed just prior to the injections and again 6 weeks later at the time of sacrifice at which point tissue was also analyzed. Myocardial function as assessed by regional wall thickening (as measured by dobutamine stress echocardiograms) demonstrated a 40.9% improvement after cell treatment of the ischemic zone (p = 0.016) whereas the saline treated animals only had a 3.7% change (p = 0.82) compared to baseline. The left ventricular ejection fractions of MSC group showed 19.5% improvement from baseline 35.9 ± 3.8% to 42.9 ± 5.8% (p = 0.049). Increased vascularity was found in the MSC group compared to controls (0.80 ± 0.30 vs 0.50 ± 0.19 capillary/myocyte ratio, p = 0.018). Direct injection of autologous MSCs promotes angiogenesis and enhances the functional improvements following chronic myocardial ischemia. This suggests that the angiogenesis engendered by cell treatment may be physiologically meaningful by improving the contractility of ischemic myocardium.

AB - Cell-based therapies have been employed with conflicting results. Whether direct injection of ex-vivo expanded autologous marrow stromal cells (MSCs) would improve the function of ischemic myocardium and enhance angiogenesis is not well defined. In a porcine model of chronic ischemia, MSCs were isolated and cultured for 4 weeks. Sixteen animals were random divided into two groups to receive either direct intramyocardial injection of autologous MSCs, or equal volumes and injections sites of saline. Cine MRI and epicardial echocardiography were performed just prior to the injections and again 6 weeks later at the time of sacrifice at which point tissue was also analyzed. Myocardial function as assessed by regional wall thickening (as measured by dobutamine stress echocardiograms) demonstrated a 40.9% improvement after cell treatment of the ischemic zone (p = 0.016) whereas the saline treated animals only had a 3.7% change (p = 0.82) compared to baseline. The left ventricular ejection fractions of MSC group showed 19.5% improvement from baseline 35.9 ± 3.8% to 42.9 ± 5.8% (p = 0.049). Increased vascularity was found in the MSC group compared to controls (0.80 ± 0.30 vs 0.50 ± 0.19 capillary/myocyte ratio, p = 0.018). Direct injection of autologous MSCs promotes angiogenesis and enhances the functional improvements following chronic myocardial ischemia. This suggests that the angiogenesis engendered by cell treatment may be physiologically meaningful by improving the contractility of ischemic myocardium.

KW - Mesenchymal stromal cells

KW - Myocardial function

KW - Myocardial ischemia

UR - http://www.scopus.com/inward/record.url?scp=70450225233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70450225233&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2009.10.074

DO - 10.1016/j.bbrc.2009.10.074

M3 - Article

C2 - 19852944

AN - SCOPUS:70450225233

VL - 390

SP - 902

EP - 907

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -